Search results
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 4 days agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 7 days agoThe Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Chegg and Moderna...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoThe EPS Rating compares a stock's recent and longer-term earnings growth against...investing, PFE...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 3 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 4 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
The CDC Took Out 148 Pages of Essential Information
Mercola· 3 days agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of the outer lining ...
We May Be Facing an Epidemic of This Brain Disease
Mercola· 7 days agoIn my 2021 interview with Stephanie Seneff, Ph.D., she explained why she suspected the COVID shots may eventually result in an avalanche of neurological prion-based diseases ...
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 4 days agoThe new omicron variant took only a few weeks to live up to dire predictions about how hugely...
16 out of 24 health care companies beat topline numbers this week- Earnings scorecard
Seeking Alpha· 1 day agoThis article provides an overview of the healthcare sector's recent quarterly earnings and highlights key companies like Pfizer, CVS Health, Moderna, Amgen,...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 4 days agoLitigation and Intellectual Property Updates Arbutus continues to defend its intellectual property vigorously, particularly in ongoing litigation with Moderna and